• 1. An amorphous carbon nitride/NiO/CoN-based composite: a highly efficient nonprecious electrode for supercapacitors and the oxygen evolution reaction?
  Huifang Yang,Haoran Guo,Peidong Fan,Xinpan Li,Wenlu Ren,Rui Song Nanoscale, 2020,12, 7024-7034
• 2. An automatic determination of thoria in thoria-urania mixtures
  Analyst, 1966,91, 208-210
• 3. An atomic scale study of defects in Co2FeAl
  Ravi Kumar Yadav,R. Govindaraj Phys. Chem. Chem. Phys., 2020,22, 26876-26886
• 4. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 5. An algal process treatment combined with the Fenton reaction for high concentrations of amoxicillin and cefradine
  Haitao Li,Yu Pan,Zhizhi Wang,Shan Chen,Ruixin Guo,Jianqiu Chen RSC Adv., 2015,5, 100775-100782

3-(Chloromethyl)-1H-pyrrolo[2,3-b]pyridine; Hydrochloride (CAS No. 1337880-19-9): An Overview

3-(Chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride (CAS No. 1337880-19-9) is a versatile compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound belongs to the class of pyrrolopyridines, which are known for their diverse biological activities and potential therapeutic applications. The presence of a chloromethyl group and the hydrochloride salt form contribute to its unique chemical and pharmacological properties, making it a valuable candidate for further investigation.

The chemical structure of 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride is characterized by a pyrrolopyridine core with a chloromethyl substituent at the 3-position. This structural feature imparts the compound with specific reactivity and binding properties, which are crucial for its biological activity. The hydrochloride salt form enhances its solubility and stability, making it more suitable for various experimental and clinical applications.

In recent years, there has been a growing interest in the development of small molecules that can modulate specific biological pathways for therapeutic purposes. 3-(Chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride has shown promise in this regard due to its ability to interact with key cellular targets. Studies have demonstrated that this compound can selectively bind to certain receptors and enzymes, leading to modulations in cellular signaling pathways that are implicated in various diseases.

One of the notable areas of research involving 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride is its potential as an anticancer agent. Preclinical studies have shown that this compound exhibits cytotoxic effects against various cancer cell lines, including those derived from breast, lung, and colon cancers. The mechanism of action appears to involve the inhibition of specific kinases and the induction of apoptosis in cancer cells. These findings suggest that 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride could be a promising lead compound for the development of novel anticancer drugs.

Beyond its anticancer properties, 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride has also been explored for its potential in neurodegenerative diseases. Research has indicated that this compound can cross the blood-brain barrier and exert neuroprotective effects by reducing oxidative stress and inflammation. These properties make it a candidate for further investigation in conditions such as Alzheimer's disease and Parkinson's disease.

The synthesis of 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride involves well-established chemical reactions that can be performed under controlled laboratory conditions. The starting materials are readily available, and the synthetic route is scalable, making it feasible for large-scale production if required. This accessibility is an important factor in the development of new pharmaceuticals, as it ensures that sufficient quantities of the compound can be produced for preclinical and clinical studies.

In addition to its biological activities, the physicochemical properties of 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride have been extensively characterized. The compound exhibits good solubility in both aqueous and organic solvents, which facilitates its use in various experimental protocols. Its stability under different conditions has also been studied, providing valuable information for storage and handling.

The safety profile of 3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride is another critical aspect that has been evaluated in preclinical studies. Toxicity assessments have shown that this compound is generally well-tolerated at therapeutic doses, with minimal adverse effects observed in animal models. However, further studies are needed to fully understand its safety profile in humans.

In conclusion, 3-(Chloromethyl)-1H-pyrrolo[2,3-b]pyridine; hydrochloride (CAS No. 1337880-19-9) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure and favorable physicochemical properties make it an attractive candidate for further research and development in medicinal chemistry and pharmaceutical sciences. Ongoing studies are expected to uncover more about its mechanisms of action and potential uses in treating various diseases.

• 72188-32-0(1H-Pyrrolo[2,3-b]pyridine-3-carbonyl chloride)
• 23612-70-6(3,4-Dimethyl-1H-pyrrolo[2,3-b]pyridine)
• 1638771-61-5(3-(chloromethyl)-1-methyl-pyrrolo[2,3-b]pyridine;hydrochloride)
• 5654-93-3(3-methyl-1H-pyrrolo[2,3-b]pyridine)
• 201537-87-3(3-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine)
• 14757-46-1(3,5-Dimethyl-1,8-naphthyridine)
• 1391088-64-4(4-(1H-Pyrrolo[2,3-b]pyridin-3-yl)-1,8-naphthyridine)
• 1268390-67-5(4-(Chloromethyl)-1H-pyrrolo[2,3-b]pyridine)
• 900514-05-8(5-(chloromethyl)-1H-pyrrolo[2,3-b]pyridine;hydrochloride)
• 479552-75-5